In non-small cell lung cancer, Rac1 is significantly up-regulated in tissues, while the knock-down of Rac1 can inhibit the invasion and migration of tumor cells and improve the sensitivity of cells to anticancer drugs [45,46]. This evidence concerns the gene RAC1 and neoplasm.